TP53 and neuroendocrine neoplasm: TP53 and RB1 are mutated in about 80% of poorly differentiated neuroendocrine neoplasms (NENs), and data from mouse models indicate that the loss of these two genes is vital to the formation of poorly differentiated NENs [21].